Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study

Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max )...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity surgery 2020-12, Vol.30 (12), p.4852-4859
Hauptverfasser: Aliakbarian, Hassan, Bhutta, Hina Y., Heshmati, Keyvan, Unes Kunju, Shebna, Sheu, Eric G., Tavakkoli, Ali
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4859
container_issue 12
container_start_page 4852
container_title Obesity surgery
container_volume 30
creator Aliakbarian, Hassan
Bhutta, Hina Y.
Heshmati, Keyvan
Unes Kunju, Shebna
Sheu, Eric G.
Tavakkoli, Ali
description Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max ) and risk of weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery. Methods One hundred five adult patients undergoing primary RYGB were prospectively recruited. Baseline demographics were recorded and fasting plasma glucose, glycosylated hemoglobin (A1C), insulin, glucagon, leptin, active ghrelin, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) levels were measured on day of surgery. Results Our cohort had a mean age of 44.4 ± 13.0 years, and initial BMI (body mass index) of 45.1 ± 6.7 kg/m 2 with mean post-operative follow-up of 40 months. Eighty patients were female and 26 had type 2 diabetes mellitus (T2D). Average WL max was 35.3 ± 7.4%. On univariate analysis, higher baseline fasting ghrelin, lower age, lower CRP (C-reactive protein), lower A1C, and negative T2D status were associated with greater WL max ( p  
doi_str_mv 10.1007/s11695-020-04877-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2430369505</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2473256108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-653fb8cd5658e8cc28269e1a289702acc0b92f19afe7cf72a145522d24a42c733</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EokPhD7BAlth0Y3p9ncQOO6joQxoJ1IcQK8vj3AypMnGwk8Ks-tdrOi1ILFhZR_7OufY9jL2W8E4C6MMkZVWXAhAEFEZroZ-whdRgskTzlC2grkCYGtUee5HSNQDKCvE521OoC4OgFuz2SyQRRopu6m6IZ9V0fgox8dDyr9Stv098GVLibmge9TmtXTfw49D34Wc3rPl5mH8JGsQ3fuLSFDvPP25Hl00Xc1xT3L7nLieHNJK_n3I6b9zAL6a52b5kz1rXJ3r1cO6zq-NPl0enYvn55Ozow1L4opCTqErVroxvyqo0ZLxHg1VN0qGpNaDzHlY1trJ2LWnfanSyKEvEBgtXoNdK7bODXe4Yw4-Z0mQ3XfLU926gMCeLhQKVtwllRt_-g16HOQ75dZnSCstKgskU7iifP5YitXaM3cbFrZVgf9djd_XYXI-9r8fqbHrzED2vNtT8sTz2kQG1A1K-GvLu_s7-T-wdfDCapQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473256108</pqid></control><display><type>article</type><title>Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Aliakbarian, Hassan ; Bhutta, Hina Y. ; Heshmati, Keyvan ; Unes Kunju, Shebna ; Sheu, Eric G. ; Tavakkoli, Ali</creator><creatorcontrib>Aliakbarian, Hassan ; Bhutta, Hina Y. ; Heshmati, Keyvan ; Unes Kunju, Shebna ; Sheu, Eric G. ; Tavakkoli, Ali</creatorcontrib><description>Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max ) and risk of weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery. Methods One hundred five adult patients undergoing primary RYGB were prospectively recruited. Baseline demographics were recorded and fasting plasma glucose, glycosylated hemoglobin (A1C), insulin, glucagon, leptin, active ghrelin, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) levels were measured on day of surgery. Results Our cohort had a mean age of 44.4 ± 13.0 years, and initial BMI (body mass index) of 45.1 ± 6.7 kg/m 2 with mean post-operative follow-up of 40 months. Eighty patients were female and 26 had type 2 diabetes mellitus (T2D). Average WL max was 35.3 ± 7.4%. On univariate analysis, higher baseline fasting ghrelin, lower age, lower CRP (C-reactive protein), lower A1C, and negative T2D status were associated with greater WL max ( p  &lt; 0.05). Controlling for these variables using stepwise multivariate regression, only higher fasting ghrelin and younger age were associated significantly with greater WL max ( p  &lt; 0.05). In subgroup multivariate regression analysis of T2D patients, higher ghrelin and glucagon were significantly associated with greater WL max . Following stepwise multivariate regression, lower initial BMI and lower glucagon were associated with greater WR ( p  &lt; 0.05). Conclusions Incorporation of baseline biological and hormonal markers may help in developing more accurate predictive models for weight loss following bariatric surgery that help inform patient counseling and decision-making.</description><identifier>ISSN: 0960-8923</identifier><identifier>EISSN: 1708-0428</identifier><identifier>DOI: 10.1007/s11695-020-04877-7</identifier><identifier>PMID: 32748203</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adult ; Blood Glucose ; Diabetes Mellitus, Type 2 ; Female ; Gastric Bypass ; Gastrointestinal surgery ; Glucagon ; Humans ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Obesity, Morbid - surgery ; Original Contributions ; Patients ; Prospective Studies ; Surgery ; Weight Gain ; Weight Loss</subject><ispartof>Obesity surgery, 2020-12, Vol.30 (12), p.4852-4859</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-653fb8cd5658e8cc28269e1a289702acc0b92f19afe7cf72a145522d24a42c733</citedby><cites>FETCH-LOGICAL-c441t-653fb8cd5658e8cc28269e1a289702acc0b92f19afe7cf72a145522d24a42c733</cites><orcidid>0000-0002-7430-1848</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11695-020-04877-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11695-020-04877-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27902,27903,41466,42535,51296</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32748203$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aliakbarian, Hassan</creatorcontrib><creatorcontrib>Bhutta, Hina Y.</creatorcontrib><creatorcontrib>Heshmati, Keyvan</creatorcontrib><creatorcontrib>Unes Kunju, Shebna</creatorcontrib><creatorcontrib>Sheu, Eric G.</creatorcontrib><creatorcontrib>Tavakkoli, Ali</creatorcontrib><title>Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study</title><title>Obesity surgery</title><addtitle>OBES SURG</addtitle><addtitle>Obes Surg</addtitle><description>Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max ) and risk of weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery. Methods One hundred five adult patients undergoing primary RYGB were prospectively recruited. Baseline demographics were recorded and fasting plasma glucose, glycosylated hemoglobin (A1C), insulin, glucagon, leptin, active ghrelin, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) levels were measured on day of surgery. Results Our cohort had a mean age of 44.4 ± 13.0 years, and initial BMI (body mass index) of 45.1 ± 6.7 kg/m 2 with mean post-operative follow-up of 40 months. Eighty patients were female and 26 had type 2 diabetes mellitus (T2D). Average WL max was 35.3 ± 7.4%. On univariate analysis, higher baseline fasting ghrelin, lower age, lower CRP (C-reactive protein), lower A1C, and negative T2D status were associated with greater WL max ( p  &lt; 0.05). Controlling for these variables using stepwise multivariate regression, only higher fasting ghrelin and younger age were associated significantly with greater WL max ( p  &lt; 0.05). In subgroup multivariate regression analysis of T2D patients, higher ghrelin and glucagon were significantly associated with greater WL max . Following stepwise multivariate regression, lower initial BMI and lower glucagon were associated with greater WR ( p  &lt; 0.05). Conclusions Incorporation of baseline biological and hormonal markers may help in developing more accurate predictive models for weight loss following bariatric surgery that help inform patient counseling and decision-making.</description><subject>Adult</subject><subject>Blood Glucose</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Female</subject><subject>Gastric Bypass</subject><subject>Gastrointestinal surgery</subject><subject>Glucagon</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Obesity, Morbid - surgery</subject><subject>Original Contributions</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Surgery</subject><subject>Weight Gain</subject><subject>Weight Loss</subject><issn>0960-8923</issn><issn>1708-0428</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kUtv1DAUhS0EokPhD7BAlth0Y3p9ncQOO6joQxoJ1IcQK8vj3AypMnGwk8Ks-tdrOi1ILFhZR_7OufY9jL2W8E4C6MMkZVWXAhAEFEZroZ-whdRgskTzlC2grkCYGtUee5HSNQDKCvE521OoC4OgFuz2SyQRRopu6m6IZ9V0fgox8dDyr9Stv098GVLibmge9TmtXTfw49D34Wc3rPl5mH8JGsQ3fuLSFDvPP25Hl00Xc1xT3L7nLieHNJK_n3I6b9zAL6a52b5kz1rXJ3r1cO6zq-NPl0enYvn55Ozow1L4opCTqErVroxvyqo0ZLxHg1VN0qGpNaDzHlY1trJ2LWnfanSyKEvEBgtXoNdK7bODXe4Yw4-Z0mQ3XfLU926gMCeLhQKVtwllRt_-g16HOQ75dZnSCstKgskU7iifP5YitXaM3cbFrZVgf9djd_XYXI-9r8fqbHrzED2vNtT8sTz2kQG1A1K-GvLu_s7-T-wdfDCapQ</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Aliakbarian, Hassan</creator><creator>Bhutta, Hina Y.</creator><creator>Heshmati, Keyvan</creator><creator>Unes Kunju, Shebna</creator><creator>Sheu, Eric G.</creator><creator>Tavakkoli, Ali</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7430-1848</orcidid></search><sort><creationdate>20201201</creationdate><title>Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study</title><author>Aliakbarian, Hassan ; Bhutta, Hina Y. ; Heshmati, Keyvan ; Unes Kunju, Shebna ; Sheu, Eric G. ; Tavakkoli, Ali</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-653fb8cd5658e8cc28269e1a289702acc0b92f19afe7cf72a145522d24a42c733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Blood Glucose</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Female</topic><topic>Gastric Bypass</topic><topic>Gastrointestinal surgery</topic><topic>Glucagon</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Obesity, Morbid - surgery</topic><topic>Original Contributions</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Surgery</topic><topic>Weight Gain</topic><topic>Weight Loss</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aliakbarian, Hassan</creatorcontrib><creatorcontrib>Bhutta, Hina Y.</creatorcontrib><creatorcontrib>Heshmati, Keyvan</creatorcontrib><creatorcontrib>Unes Kunju, Shebna</creatorcontrib><creatorcontrib>Sheu, Eric G.</creatorcontrib><creatorcontrib>Tavakkoli, Ali</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aliakbarian, Hassan</au><au>Bhutta, Hina Y.</au><au>Heshmati, Keyvan</au><au>Unes Kunju, Shebna</au><au>Sheu, Eric G.</au><au>Tavakkoli, Ali</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study</atitle><jtitle>Obesity surgery</jtitle><stitle>OBES SURG</stitle><addtitle>Obes Surg</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>30</volume><issue>12</issue><spage>4852</spage><epage>4859</epage><pages>4852-4859</pages><issn>0960-8923</issn><eissn>1708-0428</eissn><abstract>Background There are currently few pre-operative predictors of initial and long-term weight loss following bariatric surgery. Objectives We evaluated the role of pre-operative patient characteristics and baseline gut and adipose-derived hormones in predicting maximal total body weight loss (WL max ) and risk of weight regain (WR) after Roux-en-Y gastric bypass (RYGB) surgery. Methods One hundred five adult patients undergoing primary RYGB were prospectively recruited. Baseline demographics were recorded and fasting plasma glucose, glycosylated hemoglobin (A1C), insulin, glucagon, leptin, active ghrelin, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) levels were measured on day of surgery. Results Our cohort had a mean age of 44.4 ± 13.0 years, and initial BMI (body mass index) of 45.1 ± 6.7 kg/m 2 with mean post-operative follow-up of 40 months. Eighty patients were female and 26 had type 2 diabetes mellitus (T2D). Average WL max was 35.3 ± 7.4%. On univariate analysis, higher baseline fasting ghrelin, lower age, lower CRP (C-reactive protein), lower A1C, and negative T2D status were associated with greater WL max ( p  &lt; 0.05). Controlling for these variables using stepwise multivariate regression, only higher fasting ghrelin and younger age were associated significantly with greater WL max ( p  &lt; 0.05). In subgroup multivariate regression analysis of T2D patients, higher ghrelin and glucagon were significantly associated with greater WL max . Following stepwise multivariate regression, lower initial BMI and lower glucagon were associated with greater WR ( p  &lt; 0.05). Conclusions Incorporation of baseline biological and hormonal markers may help in developing more accurate predictive models for weight loss following bariatric surgery that help inform patient counseling and decision-making.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32748203</pmid><doi>10.1007/s11695-020-04877-7</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-7430-1848</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0960-8923
ispartof Obesity surgery, 2020-12, Vol.30 (12), p.4852-4859
issn 0960-8923
1708-0428
language eng
recordid cdi_proquest_miscellaneous_2430369505
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adult
Blood Glucose
Diabetes Mellitus, Type 2
Female
Gastric Bypass
Gastrointestinal surgery
Glucagon
Humans
Medicine
Medicine & Public Health
Middle Aged
Obesity, Morbid - surgery
Original Contributions
Patients
Prospective Studies
Surgery
Weight Gain
Weight Loss
title Pre-operative Predictors of Weight Loss and Weight Regain Following Roux-en-Y Gastric Bypass Surgery: a Prospective Human Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T08%3A52%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pre-operative%20Predictors%20of%20Weight%20Loss%20and%20Weight%20Regain%20Following%20Roux-en-Y%20Gastric%20Bypass%20Surgery:%20a%20Prospective%20Human%20Study&rft.jtitle=Obesity%20surgery&rft.au=Aliakbarian,%20Hassan&rft.date=2020-12-01&rft.volume=30&rft.issue=12&rft.spage=4852&rft.epage=4859&rft.pages=4852-4859&rft.issn=0960-8923&rft.eissn=1708-0428&rft_id=info:doi/10.1007/s11695-020-04877-7&rft_dat=%3Cproquest_cross%3E2473256108%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2473256108&rft_id=info:pmid/32748203&rfr_iscdi=true